Q-linea AB (publ)

Q-linea AB (publ)

QLINEA.ST
Q-linea AB (publ)SE flagStockholm Stock Exchange
0.06
SEK
+0.00
(+7.75%)
0.20EPS
0.28P/E
366.49MMarket Cap
Jul 10Next Earn
Capital Structure

in mil. unless spec.
Working Capital

in mil. unless spec.
Growth Rates

in mil. unless spec.
Quarterly Revenue

in mil. unless spec.
Quarterly Earnings Per Share

in mil. unless spec.
Quarterly Dividends Per Share

in mil. unless spec.

Company Description

CEO
Mr. Stuart Gander
Full Time Employees
97
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Address
Dag Hammarskjölds väg 52A Uppsala Sweden 752 37
IPO Date
Dec 7, 2018
Website
qlinea.com
Similar Companies
Business
Q-linea AB (publ) engages in the development of instruments and consumables for infection diagnostics in Sweden. It offers inventive systems for in vitro diagnostics systems for infectious diseases. The company's lead product candidate is ASTar, an antibiotic susceptibility testing system used for positive blood cultures. It develops and delivers solutions for healthcare providers. Q-linea AB (publ) was incorporated in 2008 and is headquartered in Uppsala, Sweden.